Coffee, Caffeine, and Health Outcomes: An Umbrella Review

Annu Rev Nutr. 2017 Aug 21:37:131-156. doi: 10.1146/annurev-nutr-071816-064941.

Abstract

To evaluate the associations between coffee and caffeine consumption and various health outcomes, we performed an umbrella review of the evidence from meta-analyses of observational studies and randomized controlled trials (RCTs). Of the 59 unique outcomes examined in the selected 112 meta-analyses of observational studies, coffee was associated with a probable decreased risk of breast, colorectal, colon, endometrial, and prostate cancers; cardiovascular disease and mortality; Parkinson's disease; and type-2 diabetes. Of the 14 unique outcomes examined in the 20 selected meta-analyses of observational studies, caffeine was associated with a probable decreased risk of Parkinson's disease and type-2 diabetes and an increased risk of pregnancy loss. Of the 12 unique acute outcomes examined in the selected 9 meta-analyses of RCTs, coffee was associated with a rise in serum lipids, but this result was affected by significant heterogeneity, and caffeine was associated with a rise in blood pressure. Given the spectrum of conditions studied and the robustness of many of the results, these findings indicate that coffee can be part of a healthful diet.

Keywords: caffeine; cancer; cardiovascular disease; coffee; diabetes; neurodegenerative disease.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Caffeine / pharmacology*
  • Cardiovascular Diseases / epidemiology
  • Coffee*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Female
  • Humans
  • Male
  • Neoplasms / epidemiology
  • Neurodegenerative Diseases / epidemiology
  • Observational Studies as Topic
  • Pregnancy
  • Randomized Controlled Trials as Topic
  • Risk

Substances

  • Coffee
  • Caffeine